News Conference News ESC 2016 When Unblinded to Statin Therapy, Patients’ Muscle-Related Adverse Events Shoot Up: ASCOT Analysis Michael O'Riordan August 31, 2016
News Conference News ESC 2016 Ezetimibe Plus Pitavastatin Fails to Lower Risk of CVD Events in ACS Patients: HIJ-PROPER Michael O'Riordan August 30, 2016
News Daily News More Bang, Less Buck: Cost-Effectiveness Analysis Says Price of PCSK9 Inhibitors Needs to Drop by Two-Thirds Yael L. Maxwell August 29, 2016
News Daily News Más con Menos: Un Análisis de Rentabilidad Dice que Hay que Reducir en Dos Tercios el Precio de PCSK9 Yael L. Maxwell August 29, 2016
News Conference News ESC 2016 Long-term Exposure to Lower LDL Cholesterol, Blood Pressure Has Potential to Dramatically Cut CV Risk Todd Neale August 29, 2016
News Daily News Noninvasive Testing Can Safely Spare a Large Proportion of Elderly Patients From Statin Therapy Michael O'Riordan August 23, 2016
News Daily News USPSTF: Not Enough Evidence to Recommend Routine Lipid Screening in Children and Adolescents Michael O'Riordan August 09, 2016
News Daily News Los Niveles Altos de Lípidos Dictados Genéticamente Parecen Proteger Frente a la Diabetes Tipo 2 Todd Neale August 04, 2016
News Daily News Las Muertes por Causas Cardiovasculares de los Astronautas del Proyecto Apolo Plantean Cuestiones de Seguridad CV en el Espacio Profundo Michael O'Riordan August 01, 2016
News Daily News Apollo Lunar Astronauts Dying of Heart Disease Pose CV Safety Questions for Deep Space Michael O'Riordan August 01, 2016
News Daily News Underuse of Medical Therapy Linked With Increased Adverse Events in Very Elderly Michael O'Riordan July 21, 2016
News Daily News La Infrautilización del Tratamiento Médico se asocia a Más Episodios Adversos en Pacientes Muy Ancianos Michael O'Riordan July 21, 2016
News Daily News Debate Directrices EU vs. EE.UU: Según los Expertos las Diferencias son Importantes Shelley Wood July 19, 2016
News Daily News AstraZeneca Strives to Block Generic Crestor as Observers Call Foul Michael O'Riordan July 13, 2016
News Daily News Time for Niacin to Be ‘Relegated to Medical History’ as HPS2-THRIVE Analysis Confirms Drug’s Failings Michael O'Riordan July 12, 2016
News Daily News Statins Lower but Don’t Erase the Excess Risk of Coronary Disease and Death in Familial Hypercholesterolemia Todd Neale July 12, 2016
News Daily News Las Estatinas Minimizan pero No Eliminan el Exceso de Riesgo de Enfermedad Coronaria y Muerte en la Hipercolesterolemia Familiar Todd Neale July 12, 2016
News Daily News Un Panel Asesor de la FDA Recomienda por un Estrecho Margen una Indicación de Mortalidad por EAC para el Antidiabético Empagliflozina Michael O'Riordan June 30, 2016
News Daily News FDA Advisory Panel Narrowly Recommends CVD Mortality Indication for Diabetes Drug Empagliflozin Michael O'Riordan June 30, 2016